{"url":"https://lda.senate.gov/api/v1/filings/f6a986c3-2630-4d3b-bbf9-e41cff83738e/","filing_uuid":"f6a986c3-2630-4d3b-bbf9-e41cff83738e","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2024,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/f6a986c3-2630-4d3b-bbf9-e41cff83738e/print/","filing_document_content_type":"text/html","income":"75000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"William Burke","dt_posted":"2024-10-22T14:57:53-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1455 Pennsylvania Ave Ste 400","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":315091,"url":"https://lda.senate.gov/api/v1/registrants/315091/","house_registrant_id":39394,"name":"RUBICON ADVISORS, LLC","description":"Lobbying firm","address_1":"1455 Pennsylvania Ave Ste 400","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"WILLIAM BURKE","contact_telephone":"+1 202-652-2290","dt_updated":"2026-07-20T10:39:00.156839-04:00"},"client":{"id":185320,"url":"https://lda.senate.gov/api/v1/clients/185320/","client_id":315,"name":"DYNAVAX TECHNOLOGIES","general_description":"Pharmaceuticals","client_government_entity":false,"client_self_select":false,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2013-02-01"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Prescription User Fee, Biomedical Advance Research and Development Authority (BARDA)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":33519,"prefix":null,"prefix_display":null,"first_name":"WILLIAM","nickname":null,"middle_name":null,"last_name":"BURKE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}